Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

14.39
Delayed Data
As of Aug 18
 +0.05 / +0.35%
Today’s Change
8.31
Today|||52-Week Range
32.74
-0.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash658.5M542.0M1.2B2.0B
 
 
 
 
 
Short Term Investment Cash-201.1M-116.9M668.0M803.3M
 
 
 
 
 
Cash & Short Term Investments659.5M543.0M1.2B2.0B
 
 
 
 
 
 
ReceivablesReceivables2.7B2.5B2.1B2.1B
 
 
 
 
 
 
InventoriesInventories1.3B1.1B1.1B1.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses--8.0M----
 
 
Other Current Assets1.0B948.0M915.0M787.0M
 
 
 
 
 
Current Assets5.7B5.1B5.3B6.0B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--2.5B----
 
 
Depreciation---1.2B----
 
 
Intangible Assets38.0B34.7B33.9B33.4B
 
 
 
 
 
Other Assets38.2B37.0B35.5B34.2B
 
 
 
 
 
Total Assets45.8B43.5B42.3B41.7B
 
 
 
 
 
 
LiabilitiesAccounts Payable358.7M324.0M368.0M371.0M
 
 
 
 
 
Short Term Debt59.0M7.0M353.0M813.0M
 
 
 
 
 
Accrued Expenses3.4B12.0M19.0M12.0M
 
 
 
 
 
Other Current Liabilities3.5B2.9B3.1B2.9B
 
 
 
 
 
Other Liabilities3.9B3.6B4.2B4.5B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.4B29.8B28.2B27.6B
 
 
 
 
 
Deferred Taxes-5.4B-5.3B-4.3B-4.1B
 
 
 
 
 
Other Liabilities1.1B1.0B954.0M859.0M
 
 
 
 
 
Total Liabilities41.5B40.3B38.3B37.7B
 
 
 
 
 
 
EquityMinority Interest-700.0K-3.0M-1.0M-1.0M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity4.2B3.2B3.9B3.9B
 
 
 
 
 
Total Shareholder Equity4.2B3.2B3.9B3.9B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding347.7M347.8M347.9M348.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.